PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale School of Medicine, New Haven, Connecticut.\', \'Department of Biostatistics, Section of Health Informatics, Yale School of Public Health, New Haven, Connecticut.\', \'Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.\', \'Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamanetworkopen.2022.0935
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 35238933
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Assessment of Clinical Effectiveness of BNT162b2 COVID-19 Vaccine in US Adolescents.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all